Fermenta Biotech Ltd

Fermenta Biotech Other Announcement

KMP Sumesh Gandhi sold a total of 3,900 equity shares in three separate market transactions on September 7, 8, and 9, 2026.

Value

₹0.20 Cr

Fermenta Biotech Partnership

Fermenta Biotech Limited signed an exclusive licence agreement with VIT Vellore to commercialize Vitamin B12 fortification technology for fermented foods, enhancing its product portfolio.

From

Vellore Institute of Technology (VIT), Vellore

Fermenta Biotech Promoter Selling: ₹2.2 Cr

Director Prashant Nagre sold 44,000 shares of Fermenta Biotech Ltd via market sale. The transaction value is Rs.2.20 Crore.

Value

₹2.20 Cr

Promoter stake change

-0.15%

Fermenta Biotech Investor Presentation: Key Takeaways

Q1FY27 revenue flat sequentially at INR 126.2 crore. Human nutrition volume grew 18% QoQ, offsetting animal nutrition weakness. EBITDA stood at INR 22.4 crore (17.7% margin).

Fermenta Biotech Q1 FY27 Results: Net Profit ₹9.5 Cr, Down 56.0% YoY

Fermenta Biotech Ltd reported revenue from operations of ₹121.8 Cr (-10.6% YoY) and net profit of ₹9.5 Cr (-56.0% YoY) for Q1 FY27.

Key figure

Net profit ₹9.5 Cr · -56.0% YoY

Fermenta Biotech Earnings Call: Key Takeaways

Fermenta Biotech delivered core revenue growth of 27% YoY in FY26, driven by Vitamin D3 segments, despite headline declines from a high real-estate base in FY25.

Fermenta Biotech Q4 FY26 Results: Net Profit ₹18.6 Cr, Down 44.1% YoY

Fermenta Biotech Ltd reported revenue from operations of ₹121.6 Cr (-13.0% YoY) and net profit of ₹18.6 Cr (-44.1% YoY) for Q4 FY26.

Key figure

Net profit ₹18.6 Cr · -44.1% YoY